The time is now: Achieving FH paediatric screening across
Europe – The Prague Declaration

CSLog in Log in (EduId)

The time is now: Achieving FH paediatric screening across Europe – The Prague Declaration

Přehled o publikaci

J 2022

The time is now: Achieving FH paediatric screening across Europe – The Prague Declaration

BEDLINGTON, Nicole; Marianne ABIFADEL; Birgit BEGER; Mafalda BOURBON; Héctor BUENO et. al.

Basic information

Original name

The time is now: Achieving FH paediatric screening across Europe – The Prague Declaration

Authors

Edition

GMS health innovation and technologies, Köln, EuroScan International Network e.V. 2022, 2698-6388

Other information

Language

English

Type of outcome

Article in a journal

Country of publisher

Germany

Confidentiality degree

is not subject to a state or trade secret

References:

URL

Organization

Lékařská fakulta – Repository – Repository

DOI

http://dx.doi.org/10.3205/hta000136

Keywords in English

CVD; CVH; EU; EU best practice; Europe; FH; cardiovascular disease; cardiovascular health; children; declaration; familial hypercholesterolaemia; health systems; implementation; prevention; public health; screening

Links

LX22NPO5104, research and development project.

Changed: 5/1/2023 04:01, RNDr. Daniel Jakubík

Abstract

V originále

Familial hypercholesterolaemia (FH) is the most common inherited metabolic disorder characterized by high cholesterol and if left untreated leads to premature cardiovascular disease, such as heart attacks. Treatment that begins early in life, particularly in childhood, is highly efficacious in preventing cardiovascular disease and cost-effective, thus early detection of FH is crucial. However, in Europe, less than 10% of people living with FH are diagnosed and even less receive life-saving treatment. The Prague Declaration is a call to action for national and European Union policymakers and decision-makers and a result of the Czech EU Presidency meeting on FH Paediatric Screening (early detection of inherited high cholesterol) at the Czech Senate in Prague on 6th September 2022. It builds on a considerable body of evidence which was discussed at the Technical Meeting under the auspices of the Slovenian EU Presidency in October 2021. The Prague meeting addressed the outstanding barriers to the systematic implementation of FH paediatric screening across Europe. In this article, we present the key points from the Prague meeting and concrete actions needed to move forward.

Files attached

https://is.muni.cz/publication/2243423/The_time_is_now__Achieving_FH_paediatric_screening_across_Europe_-_The_Prague_Declaration

Cite

BEDLINGTON, Nicole; Marianne ABIFADEL; Birgit BEGER; Mafalda BOURBON; Héctor BUENO; Richard CESKA; Kristýna CILLÍKOVÁ; Zdenka CIMICKÁ; Magdalena DACCORD; Carine de BEAUFORT; Kanika I DHARMAYAT; Brian A FERENCE; Tomáš FREIBERGER; Marius GEANTA; Samuel S GIDDING; Urh GROŠELJ; Martin HALLE; Neil JOHNSON; Tanja NOVAKOVIC; Ondřej MÁJEK; Athanasios PALLIDIS; Noel PERETTI; Fausto J PINTO; Kausik Kosh RAY; Bleddyn REES; John REEVE; Željko REINER; Raul D SANTOS; Heribert SCHUNKERT; Jaka ŠIKONJA; Milka SOKOLOVIC; Lale TOKGÖZOGLU; Michal VRABLÍK; Albert WIEGMAN and Iñaki GUTIÉRREZ-IBARLUZEA. The time is now: Achieving FH paediatric screening across Europe – The Prague Declaration. GMS health innovation and technologies. Köln: EuroScan International Network e.V., 2022, vol. 16, September 2022, p. 1-8. ISSN 2698-6388. Available from: https://dx.doi.org/10.3205/hta000136.

@article{53514,
   author = {Bedlington, Nicole and Abifadel, Marianne and Beger, Birgit and Bourbon, Mafalda and Bueno, Héctor and Ceska, Richard and Cillíková, Kristýna and Cimická, Zdenka and Daccord, Magdalena and Beaufort, Carine de and Dharmayat, Kanika I and Ference, Brian A and Freiberger, Tomáš and Geanta, Marius and Gidding, Samuel S and Grošelj, Urh and Halle, Martin and Johnson, Neil and Novakovic, Tanja and Májek, Ondřej and Pallidis, Athanasios and Peretti, Noel and Pinto, Fausto J and Ray, Kausik Kosh and Rees, Bleddyn and Reeve, John and Reiner, Željko and Santos, Raul D and Schunkert, Heribert and Šikonja, Jaka and Sokolovic, Milka and Tokgözoglu, Lale and Vrablík, Michal and Wiegman, Albert and GutiérrezandIbarluzea, Iñaki},
   article_location = {Köln},
   article_number = {September 2022},
   doi = {http://dx.doi.org/10.3205/hta000136},
   keywords = {CVD; CVH; EU; EU best practice; Europe; FH; cardiovascular disease; cardiovascular health; children; declaration; familial hypercholesterolaemia; health systems; implementation; prevention; public health; screening},
   language = {eng},
   issn = {2698-6388},
   journal = {GMS health innovation and technologies},
   title = {The time is now: Achieving FH paediatric screening across Europe – The Prague Declaration},
   url = {https://www.egms.de/static/en/journals/hta/2022-16/hta000136.shtml},
   volume = {16},
   year = {2022}
}

TY  - JOUR
ID  - 53514
AU  - Bedlington, Nicole - Abifadel, Marianne - Beger, Birgit - Bourbon, Mafalda - Bueno, Héctor - Ceska, Richard - Cillíková, Kristýna - Cimická, Zdenka - Daccord, Magdalena - Beaufort, Carine de - Dharmayat, Kanika I - Ference, Brian A - Freiberger, Tomáš - Geanta, Marius - Gidding, Samuel S - Grošelj, Urh - Halle, Martin - Johnson, Neil - Novakovic, Tanja - Májek, Ondřej - Pallidis, Athanasios - Peretti, Noel - Pinto, Fausto J - Ray, Kausik Kosh - Rees, Bleddyn - Reeve, John - Reiner, Željko - Santos, Raul D - Schunkert, Heribert - Šikonja, Jaka - Sokolovic, Milka - Tokgözoglu, Lale - Vrablík, Michal - Wiegman, Albert - Gutiérrez-Ibarluzea, Iñaki
PY  - 2022
TI  - The time is now: Achieving FH paediatric screening across Europe – The Prague Declaration
JF  - GMS health innovation and technologies
VL  - 16
IS  - September 2022
SP  - 1-8
EP  - 1-8
PB  - EuroScan International Network e.V.
SN  - 2698-6388
KW  - CVD
KW  - CVH
KW  - EU
KW  - EU best practice
KW  - Europe
KW  - FH
KW  - cardiovascular disease
KW  - cardiovascular health
KW  - children
KW  - declaration
KW  - familial hypercholesterolaemia
KW  - health systems
KW  - implementation
KW  - prevention
KW  - public health
KW  - screening
UR  - https://www.egms.de/static/en/journals/hta/2022-16/hta000136.shtml
N2  - Familial hypercholesterolaemia (FH) is the most common inherited metabolic disorder characterized by high cholesterol and if left untreated leads to premature cardiovascular disease, such as heart attacks. Treatment that begins early in life, particularly in childhood, is highly efficacious in preventing cardiovascular disease and cost-effective, thus early detection of FH is crucial. However, in Europe, less than 10% of people living with FH are diagnosed and even less receive life-saving treatment. The Prague Declaration is a call to action for national and European Union policymakers and decision-makers and a result of the Czech EU Presidency meeting on FH Paediatric Screening (early detection of inherited high cholesterol) at the Czech Senate in Prague on 6th September 2022. It builds on a considerable body of evidence which was discussed at the Technical Meeting under the auspices of the Slovenian EU Presidency in October 2021. The Prague meeting addressed the outstanding barriers to the systematic implementation of FH paediatric screening across Europe. In this article, we present the key points from the Prague meeting and concrete actions needed to move forward.
ER  -

BEDLINGTON, Nicole; Marianne ABIFADEL; Birgit BEGER; Mafalda BOURBON; Héctor BUENO; Richard CESKA; Kristýna CILLÍKOVÁ; Zdenka CIMICKÁ; Magdalena DACCORD; Carine de BEAUFORT; Kanika I DHARMAYAT; Brian A FERENCE; Tomáš FREIBERGER; Marius GEANTA; Samuel S GIDDING; Urh GROŠELJ; Martin HALLE; Neil JOHNSON; Tanja NOVAKOVIC; Ondřej MÁJEK; Athanasios PALLIDIS; Noel PERETTI; Fausto J PINTO; Kausik Kosh RAY; Bleddyn REES; John REEVE; Željko REINER; Raul D SANTOS; Heribert SCHUNKERT; Jaka ŠIKONJA; Milka SOKOLOVIC; Lale TOKGÖZOGLU; Michal VRABLÍK; Albert WIEGMAN and Iñaki GUTIÉRREZ-IBARLUZEA. The time is now: Achieving FH paediatric screening across Europe – The Prague Declaration. \textit{GMS health innovation and technologies}. Köln: EuroScan International Network e.V., 2022, vol.~16, September 2022, p.~1-8. ISSN~2698-6388. Available from: https://dx.doi.org/10.3205/hta000136.